Cardiology
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
Conference Coverage
First-line AFib ablation cuts risk of progression vs. drug therapy
Atrial fibrillation treated with ablation rather than drug therapy was less likely to progress to persistent symptoms in the PROGRESSIVE-AF trial...
Conference Coverage
If a saphenous graft is available, treat limb threatening ischemia surgically
Surgery beats endovascular treatment for limb threatening ischemia when saphenous grafts are an option, according to the BEST-CLI trial.
Conference Coverage
EHR-based thromboembolism risk tool boosted prophylaxis
A thromboembolism risk calculator in a hospital’s EHR led to a significant rise in appropriate thromboprophylaxis and a drop in thromboembolic...
From the Journals
‘Lucid dying’: EEG backs near-death experience during CPR
“Recalled experiences and brain wave changes may be the first signs of the so-called near-death experience.”
Conference Coverage
Chinese herbal medicine may offer benefits in STEMI: CTS-AMI
Treatment with tongxinluo was tied to better outcomes out to 1 year, but observers say further data are needed to see how it may fit into STEMI...
Conference Coverage
Precision CAD testing shows 70% cut in composite risk at 1 year
A streamlined protocol for evaluating suspected stable chest pain substantially improved outcomes at 1 year in the PRECISE trial.
Conference Coverage
Avoid routine early ECMO in severe cardiogenic shock: ECMO-CS
Early ECMO in this setting is increasingly common, but it didn’t seem to improve outcomes in the trial, compared with a more conservative approach...
Conference Coverage
No survival advantage for either torsemide or furosemide in HF: TRANSFORM-HF
One loop diuretic is the most widely used in heart failure, the other may have advantages in some situations, but there’s been no head-to-head...
Conference Coverage
Acute heart failure risk assessment in ED improves outcomes: COACH
Systematic risk assessment of patients with acute heart failure in the ED significantly cut their 30-day and 20-month cardiovascular...
Conference Coverage
Combo thrombolytic approach fails to reduce ICH in stroke
Although there were promising signs of a potential reduced bleeding risk in intracranial hemorrhage, the DUMAS study showed no benefit on the...